Literature DB >> 36255039

Association of Probiotic Treatment With Antibiotics in Male Accessory Gland Infections.

Giuseppe Grande1,2,3, Giuseppina Pompa1,2, Anna Laura Astorri1,2, Alfredo Pontecorvi1,2, Domenico Milardi1,2.   

Abstract

Male accessory gland infection (MAGI) represents a frequent disease, commonly treated with antibiotics alone. However, in approximately 40% to 50% of patients, persistent infection is detected. Intestinal dysbiosis is involved in the pathogenesis of prostatitis. We aimed to evaluate the efficacy of antibiotic treatment in association with a specific probiotic supplementation. A total of 104 infertile patients, with microbiological analysis on semen and/or prostatic secretions positive for Gram-negative bacteria, have been enrolled. All patients received antibiotic treatment with fluoroquinolones. In total, 84 patients received a commercial association of Enterococcus faecium and Saccharomyces boulardii during antibiotic treatment, followed by treatment with Lactobacilli. After the treatment, a complete microbiological analysis was repeated. Polymicrobial infections have been observed in 11% of patients, while infections due to a single germ were reported in 89% of the patients. After the treatment was performed, a complete eradication with negative semen culture and microbiological analysis on prostatic secretion was observed in 64 of 84 patients (76.2%), while only 10 of 20 patients receiving antibiotics alone (50%; p < .05) reported negative microbiological analysis. Persistent infections have been observed only in patients with infections due to Enterococcus faecalis and Escherichia coli. This study represents the first approach demonstrating the efficacy of a specific probiotic treatment in reducing the rate of persistent infections in patients with MAGI.

Entities:  

Keywords:  Lactobacilli; MAGI; Saccharomyces boulardii; probiotic; prostatitis

Mesh:

Substances:

Year:  2022        PMID: 36255039      PMCID: PMC9583205          DOI: 10.1177/15579883221119064

Source DB:  PubMed          Journal:  Am J Mens Health        ISSN: 1557-9883


  35 in total

Review 1.  Role played by lactobacilli in controlling the population of vaginal pathogens.

Authors:  S Boris; C Barbés
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

2.  EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU).

Authors:  K G Naber; B Bergman; M C Bishop; T E Bjerklund-Johansen; H Botto; B Lobel; F Jinenez Cruz; F P Selvaggi
Journal:  Eur Urol       Date:  2001-11       Impact factor: 20.096

Review 3.  Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.

Authors:  Alain L Servin
Journal:  FEMS Microbiol Rev       Date:  2004-10       Impact factor: 16.408

4.  Seminal microbiome in men with and without prostatitis.

Authors:  Reet Mändar; Margus Punab; Paul Korrovits; Silver Türk; Kristo Ausmees; Eleri Lapp; Jens-Konrad Preem; Kristjan Oopkaup; Andres Salumets; Jaak Truu
Journal:  Int J Urol       Date:  2017-02-01       Impact factor: 3.369

5.  Ultrasonographic evaluation of patients with male accessory gland infection.

Authors:  S La Vignera; A E Calogero; R A Condorelli; L O Vicari; M Catanuso; R D'Agata; E Vicari
Journal:  Andrologia       Date:  2011-09-15       Impact factor: 2.775

Review 6.  The gut microbiota: A treasure for human health.

Authors:  Daotong Li; Pan Wang; Pengpu Wang; Xiaosong Hu; Fang Chen
Journal:  Biotechnol Adv       Date:  2016-08-31       Impact factor: 14.227

Review 7.  Male accessory gland infection and sperm parameters (review).

Authors:  S La Vignera; E Vicari; R A Condorelli; R D'Agata; A E Calogero
Journal:  Int J Androl       Date:  2011-06-22

8.  Prednisone treatment in infertile patients with oligozoospermia and accessory gland inflammatory alterations.

Authors:  D Milardi; G Luca; G Grande; M Ghezzi; N Caretta; G Brusco; G De Filpo; R Marana; A Pontecorvi; R Calafiore; C Foresta; A Garolla
Journal:  Andrology       Date:  2017-01-26       Impact factor: 3.842

Review 9.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

10.  Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3.

Authors:  Enzo Vicari; Sandro La Vignera; Roberto Castiglione; Rosita A Condorelli; Lucia O Vicari; Aldo E Calogero
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.